Feasibility and safety of short-duration aerobic training in non-hematological cancer patients hospitalized for chemotherapy treatment [0.03%]
非血液系统癌症住院化疗患者的短时有氧运动的安全性和可行性研究
William de Lima Selles,Leticia Jeremias Ferreira Pereira,Giovanni Marini Moura et al.
William de Lima Selles et al.
Background: It is unclear whether moderate-intensity aerobic exercise is feasible and safe for inpatients with non-hematological cancer receiving one cycle of chemotherapy. ...
Esther Garcia-Lorenzo,Miriam Dorta,Bernard Doger et al.
Esther Garcia-Lorenzo et al.
T-cell engagers (TCEs) are a diverse class of bispecific and multispecific molecules that co-bind CD3 on T cells and tumor-associated antigens to form an immune synapse and induce targeted T-cell-mediated cytotoxicity. While TCEs have demon...
PEComas: Current Concepts in Diagnosis, Molecular Pathways, and Emerging Treatments [0.03%]
PECom瘤的诊断、分子途径及新兴治疗手段的最新研究进展
Giada Del Baldo,Giuseppe Maria Milano,Angela Mastronuzzi
Giada Del Baldo
Background: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms with distinct histopathological, immunophenotypic, and molecular features. Described in the early 1990s, they include angiomyolipom...
In Reply to: "Response to intra-arterial chemotherapy in patients with adenoid cystic carcinoma of lacrimal gland" [0.03%]
对泪腺腺样囊性癌血管内化疗的回复
Philippos Apolinario Costa,David T Tse,Pasquale Benedetto
Philippos Apolinario Costa
Effect of a Patient Decision Aid on Shared Decision Making in Patients with Differentiated Thyroid Cancer: A Randomized Controlled Trial [0.03%]
甲状腺癌患者共同决策支持手册随机对照试验的疗效分析
Anna Koot,Petronella Ottevanger,Rosella Hermens et al.
Anna Koot et al.
Background: Over the last decades optimal treatment for patients with differentiated thyroid cancer (DTC) is debated. Two treatment decisions for patients who could benefit from more individualized approaches and shared d...
Association of IDH1 mutations with survival and recurrence in resected intrahepatic cholangiocarcinoma received or not received adjuvant chemotherapy [0.03%]
IDH1突变与可切除肝内胆管癌术后生存及复发的关系及其是否接受辅助化疗的影响
Pengcheng Wang,Ning Li,Yuhang Ye et al.
Pengcheng Wang et al.
Background: IDH1 mutations are causal in tumor development and progression; however, their association with disease characteristics, prognosis, and therapy response in patients with resected intrahepatic cholangiocarcinom...
Comment on "how the addition of selinexor/bortezomib/dexamethasone as a Category 1 recommendation may erode outcomes" [0.03%]
关于“添加_selinexor/硼替佐米/地塞米松_作为一类建议如何侵蚀结果”的评论
Joshua Richter,Michael Davis,Yi Chai
Joshua Richter
Patrícia Fontão,Marta Viana-Pereira,Filipa Pinto-Ribeiro et al.
Patrícia Fontão et al.
Background: Medulloblastoma is the most common malignant brain tumor in children. Medulloblastoma has intrinsic characteristics that pose significant challenges to effective immunotherapy. Nevertheless, several clinical t...
Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient [0.03%]
成人神经母细胞瘤患者的全面分子分析以指导诊断和治疗
Damian T Rieke,Stefan Schwartz,Sebastian Ochsenreither et al.
Damian T Rieke et al.
Metastatic cancers of unknown primary (CUP) pose significant diagnostic and therapeutic challenges. We present the case of a 63-year old male patient with a CUP showing neuroendocrine differentiation, metastasized to the iliac bone, bone ma...